英国消费者健康检测的许多宣传缺乏证据支持
Many claims for health tests marketed to UK consumers are unsubstantiated
一项对50家商业检测机构的评估发现,许多健康检测的宣传缺乏证据支持,且未充分披露潜在风险。研究指出,这些检测可能带来误诊、过度治疗等风险,呼吁加强监管以保护消费者和NHS。
Many of the claims made for the benefits of health tests marketed to U.K. consumers are unsubstantiated, with little information provided on their potential harms and limitations, finds an assessment of the websites of 50 commercial test vendors, published in the journal BMJ Open.
The sector is predicted to increase globally from $1.6 billion in 2023 to $3.2 billion by 2029, so there's an urgent need for stronger regulatory protection for consumers, insist the researchers.
Commercial tests can include blood tests, medical imaging, physical examination and physiological testing, sold individually or in "packages," explain the researchers.
But there is scant evidence of their effectiveness in healthy people, and concerns have been raised about their accuracy and the risk of false-positive/false-negative results, overdiagnosis, overtreatment and "mental and/or physical harm," they add.
The researchers therefore wanted to gauge the current availability of commercially available screening tests marketed to U.K. consumers and to find out whether current practice protects them and the NHS from the consequences of inappropriate testing.
They identified a sample of 50 U.K. individuals, companies and clinics—including major providers—promoting health tests to healthy people in the U.K. online.
The tests included blood tests (e.g., full blood counts, liver function, genetic testing); urine, stool and saliva tests (e.g., urinary protein, gut microbiome, cortisol); physiological tests (e.g., pulmonary function tests, grip strength and ECGs); medical imaging (e.g., chest X-rays, MRI and ultrasound scans); and physical examination (e.g., pelvic and breast examinations).
Clinics offered a wide range of tests for healthy people, which aren't recommended by the NHS. Prices ranged from £6.99 ("Kidney Albumin Rapid Test" for urine, taken at home) to £14,000 ("Platinum Assessment," multiple tests carried out in a clinic).
Many "health checks" were sold in "packages." The "well woman premium assessment" or "executive MOT" could contain multiple tests and types of tests, for example. Other sales included packages with additional "add-ons."
While many vendors described in detail the tests on offer, others simply stated, for example, "vital blood checks" without specifying which ones were being tested. Some clinics stated that doctors "may recommend" other tests after discussion on the day.
Contrary to NHS advice and guidelines, 12 vendors offered mammograms to normal-risk, symptomless women under the age of 50; 45 offered to test lipids and HbA1c (for fasting blood glucose) to well adults under 40; 31 offered follicle-stimulating hormone tests to all women over 45; and 28 offered qFIT (to test for hidden blood in the stool) to adults under 50.
Thirteen organizations offered breast exams and nine offered pelvic exams to people without any worrying symptoms; 14 offered testicular exams. The NHS doesn't recommend these for people who don't have symptoms, note the researchers.
Thirty-six of the 50 vendors made claims for earlier diagnosis and better outcomes; 48 made claims for better knowledge of health; 16 made claims for living longer, despite no evidence for this; and 25 made a claim for reassurance.
Most (70%) of the vendors didn't explain the limitations of testing or its potential harms, including those of intimate physical examinations. In all, 15 made mention, either in full or partially, of the downsides of testing; nine on overdiagnosis or false positives; eight on underdiagnosis or false negatives; and nine on inaccuracy.
Despite some vendors including a report with a doctor, many still asked purchasers to involve their own (NHS) doctor.
The Care Quality Commission regulated 36 vendors, and doctors either owned or worked with 41. Nurses worked in 11 organizations, pharmacists in three, and a health care assistant in one. But there was little information on any of this on many of the websites, note the researchers.
The researchers also canvassed the views of a group of citizens brought together for the purposes of this study. Their reasons for considering commercial tests included ease of access and hoping a purchase would assist NHS interactions. But they also expressed the need for help with understanding test results: several clinics offered this only on payment of an additional fee.
The dynamic nature of the internet searches may have led to some tests available to the public being missed, and the search was limited to the U.K., acknowledge the researchers. Not all information about tests given to customers may have been available online either, they add.
"While it is possible that appropriate, high-quality health testing bought directly by consumers could fill gaps in NHS service delivery, it is also possible that poor-quality screening tests will negatively impact citizens through false positives (false alarms), false negatives (false reassurance) and loss of personal resources with little or no value gained by individuals," they point out.
"NHS primary care is already experiencing the impacts of follow-up of test results initiated by consumers rather than the NHS," they highlight.
And they conclude: "Compared with the sale of pharmaceutical products, there are far more safeguards around sales, advertising, promotion and regulation of providers. The regulation around sales of health tests to the public is far less developed, despite their capability of harm.
"We suggest that gaps in regulation, particularly proactive approaches to health claims, should be urgently addressed."
Publication details
Mapping the range of tests commercially marketed as screening tests to asymptomatic people in the UK in comparison to those recommended by the NHS: a cross-sectional study, BMJ Open (2026). DOI: 10.1136/bmjopen-2026-117741
Journal information: BMJ Open
Key medical concepts
Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Many claims for health tests marketed to UK consumers are unsubstantiated (2026, November 17) retrieved 18 November 2026 from https://medicalxpress.com/news/2026-11-health-uk-consumers-unsubstantiated.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com